Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PML4 induces differentiation by Myc destabilization.

M Buschbeck1, I Uribesalgo, A Ledl

  • 1Centre de Regulació Genòmica (CRG)/PRBB and Universitat Pompeu Fabra, Barcelona, Spain.

Oncogene
|December 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

The American journal of gastroenterology·2018
Same author

Individualized lung recruitment maneuver guided by pulse-oximetry in anesthetized patients undergoing laparoscopy: a feasibility study.

Acta anaesthesiologica Scandinavica·2018
Same author

Erratum: Observation of the hyperfine spectrum of antihydrogen.

Nature·2017
Same author

Correlates of ideal cardiovascular health in European adolescents: The HELENA study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
Same author

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Antihydrogen accumulation for fundamental symmetry tests.

Nature communications·2017

Promyelocytic leukemia (PML) protein promotes cell differentiation by destabilizing the oncogene c-Myc. This interaction reactivates tumor suppressor genes, preventing uncontrolled cell proliferation.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Hematopoiesis

Background:

  • c-Myc functions as an oncogene, inhibiting hematopoietic precursor cell differentiation.
  • Promyelocytic leukemia (PML) protein is known to suppress tumors and promote differentiation.

Purpose of the Study:

  • To investigate the interaction between PML and c-Myc.
  • To elucidate the mechanism by which PML influences cell differentiation and c-Myc activity.

Main Methods:

  • In vivo complex formation analysis between PML and c-Myc.
  • Assessment of Myc destabilization dependent on PML's RING domain.
  • Analysis of PML isoform-specific effects on Myc.
  • Quantification of promoter-bound Myc on target genes.
  • Evaluation of cell cycle inhibitor gene re-activation.

Related Experiment Videos

Main Results:

  • PML and c-Myc form a complex in vivo.
  • PML binding leads to c-Myc destabilization, dependent on PML's RING domain.
  • PML isoform 4 (PML4) specifically destabilizes c-Myc.
  • PML-induced c-Myc destabilization reduces promoter-bound Myc on repressed genes.
  • Re-activation of Myc-repressed genes, including cell cycle inhibitors cdkn1a/p21 and cdkn2b/p15, was observed.

Conclusions:

  • PML promotes cell differentiation by destabilizing the oncogene c-Myc.
  • PML-mediated destabilization of c-Myc and subsequent derepression of cell cycle inhibitors is a key regulatory mechanism.
  • This pathway prevents aberrant proliferation driven by excessive c-Myc activity, highlighting its role in tumor suppression.